Physician
Tennessee Oncology PLLC
Tennessee Oncology PLLC was paid $8.55M by Medicaid between Jan 2018 and Dec 2024, across 77 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 22% of everything it billed.
33Billing provider infoTENNESSEE ONCOLOGY PLLC
NASHVILLE, TN 37203
NASHVILLE, TN 37203
33aNPI1811955917assigned 05/01/2006
33bProvider typeSurgery Physician
28Total paid$8.55M
24GClaims811,653
24DCodes billed77
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Surgery Physician providers in Tennessee
Rank by total paid#2 of 87
Median peer was paid$9K
This provider vs. median941×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 87,379 | $842K | |
| 2019 | 100,719 | $993K | |
| 2020 | 92,169 | $1.09M | |
| 2021 | 117,639 | $1.30M | |
| 2022 | 128,922 | $1.27M | |
| 2023 | 150,651 | $1.79M | |
| 2024incomplete | 134,174 | $1.27M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 22% | 57,960 | 45,057 | $1.86M |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 19% | 29,331 | 15,130 | $1.65M |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 16% | 29,397 | 20,588 | $1.34M |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 11% | 277,438 | 174,346 | $951K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 5.4% | 20,741 | 17,765 | $459K |
| 80053 | Comprehensive metabolic panel | 4.4% | 104,444 | 74,612 | $376K |
| 88185 | 3.9% | 1,602 | 1,322 | $333K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 3.8% | 9,449 | 5,595 | $323K |
| 36415 | Collection of venous blood by venipuncture | 1.7% | 161,806 | 115,283 | $149K |
| 96367 | 1.7% | 7,388 | 3,967 | $148K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.6% | 22,911 | 14,386 | $139K |
| 82728 | 1.4% | 20,542 | 17,391 | $121K |
65 more codes
| J1439 | Injection, ferric carboxymaltose, 1 mg | <1% | 178 | $76K |
| J1756 | Injection, iron sucrose, 1 mg | <1% | 1,129 | $71K |
| 88189 | <1% | 2,509 | $62K | |
| 83550 | <1% | 16,357 | $61K | |
| 88374 | <1% | 605 | $57K | |
| 83540 | <1% | 16,609 | $46K | |
| 88184 | <1% | 1,588 | $29K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 425 | $25K |
| 81206 | <1% | 523 | $25K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 1,830 | $23K |
| 96417 | <1% | 677 | $20K | |
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | <1% | 170 | $18K |
| 88377 | <1% | 194 | $18K | |
| J0185 | Injection, aprepitant, 1 mg | <1% | 108 | $17K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 232 | $16K |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 538 | $15K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 202 | $15K |
| 82607 | <1% | 1,357 | $9K | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 2,778 | $8K |
| 78815 | Positron emission tomography (PET) for limited area imaging | <1% | 15 | $7K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 9,562 | $7K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 277 | $6K |
| 81219 | <1% | 113 | $6K | |
| 99205 | Prolong outpt/office vis | <1% | 61 | $5K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 700 | $5K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 310 | $4K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 775 | $4K |
| 81403 | <1% | 58 | $4K | |
| 88313 | <1% | 76 | $4K | |
| 81279 | <1% | 56 | $3K | |
| 81402 | <1% | 58 | $3K | |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 115 | $3K |
| 82746 | <1% | 474 | $3K | |
| 81270 | <1% | 103 | $3K | |
| 81450 | <1% | 142 | $3K | |
| 81338 | <1% | 56 | $3K | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 4,193 | $2K |
| J1627 | Injection, granisetron, extended-release, 0.1 mg | <1% | 92 | $2K |
| 83615 | <1% | 921 | $2K | |
| 83735 | <1% | 452 | $1K | |
| J2469 | Injection, palonosetron hcl, 25 mcg | <1% | 47 | $1K |
| 0011A | <1% | 71 | $1K | |
| 0012A | <1% | 44 | $1K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 15 | $903.54 |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 62 | $794.86 |
| 90688 | <1% | 58 | $735.45 | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 263 | $709.05 |
| 88360 | <1% | 29 | $706.92 | |
| 82248 | <1% | 256 | $687.74 | |
| J9045 | Injection, carboplatin, 50 mg | <1% | 147 | $652.85 |
| 84100 | <1% | 335 | $486.88 | |
| 84550 | <1% | 256 | $419.88 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 12 | $216.72 |
| 82784 | <1% | 16 | $154.82 | |
| 83521 | <1% | 16 | $150.96 | |
| 86334 | <1% | 16 | $124.06 | |
| 85045 | <1% | 50 | $109.76 | |
| J9267 | Injection, paclitaxel, 1 mg | <1% | 25 | $97.95 |
| 88311 | <1% | 62 | $96.89 | |
| 86300 | <1% | 12 | $74.59 | |
| 84165 | <1% | 16 | $59.62 | |
| 85652 | <1% | 35 | $47.79 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 73 | $2.23 |
| J1453 | Injection, fosaprepitant, 1 mg | 0% | 43 | $0.00 |
| J3490 | Unclassified drugs | 0% | 67 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialDOUGLAS, PATTIE (PAYER RELATIONS MANAGER)
| Provider | Location | Paid |
|---|---|---|
| Tennessee Oncology,pllc | Nashville, TN | $50K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.